DAFIDA

Dead / Abandoned — Abandoned — no statement of use filed (as of 31 Mar 2020)

What this means for you

This application is over — abandoned 31 Mar 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
87174403
Mark type
Stylized text
Filed
16 Sept 2016
Published for opposition
31 Jan 2017
Abandoned
31 Mar 2020

Goods and services

  • Class 005 — Pharmaceuticals: Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; Pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and formulations pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body

Owner

Prosecution history

  • 03 Jun 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 02 Jun 2020 — ABANDONMENT - NO USE STATEMENT FILED
  • 17 Jul 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 16 Jul 2019 — SOU EXTENSION 5 GRANTED
  • 11 Jul 2019 — SOU EXTENSION 5 FILED
  • 11 Jul 2019 — SOU TEAS EXTENSION RECEIVED
  • 28 Mar 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 26 Mar 2019 — SOU EXTENSION 4 GRANTED
  • 26 Mar 2019 — SOU EXTENSION 4 FILED
  • 26 Mar 2019 — SOU TEAS EXTENSION RECEIVED
  • 19 Sept 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 17 Sept 2018 — SOU EXTENSION 3 GRANTED
  • 17 Sept 2018 — SOU EXTENSION 3 FILED
  • 17 Sept 2018 — SOU TEAS EXTENSION RECEIVED
  • 20 Feb 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

View this trademark record on Marksy